Streetbeat News

Stock Prices

ASLN

ATRA

CYTO

DMK

ENSC

GLTO

NCNA

NUWE

ONCT

PETV

SXTP

WORX

In Thursday's after-market session, several healthcare stocks experienced significant movements. NuCana, Galecto, Ensysce Biosciences, Atara Biotherapeutics, 60 Degrees, and PetVivo Holdings saw their shares rise, with increases ranging from 7.75% to 15.6%. Conversely, Oncternal Therapeutics, Altamira Therapeutics, Nuwellis, DMK Pharmaceuticals, ASLAN Pharma, and SCWorx saw their shares decline, with decreases ranging from 5.65% to 12.7%. These movements reflect changes in investor sentiment and market dynamics for these small-cap companies.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:31 pm

ARBK

ATGL

CPTN

EGIO

KERN

MIMO

MLGO

QUBT

RTC

SMSI

SNCR

VRME

In Thursday's after-market session, several information technology stocks saw movement. Edgio (EGIO) shares rose 6.4%, Alpha Technology Group (ATGL) increased by 6.2%, and Quantum Computing (QUBT) went up by 5.17%. Airspan Networks Hldgs (MIMO), Cepton (CPTN), and MicroAlgo (MLGO) also saw gains. Conversely, Baijiayun Group (RTC), VerifyMe (VRME), Akerna (KERN), Smith Micro Software (SMSI), Synchronoss Technologies (SNCR), and Argo Blockchain (ARBK) experienced declines.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:31 pm

SSYS

Stratasys Ltd. (NASDAQ:SSYS) has adopted a new limited duration shareholder rights plan, replacing the one expiring on December 31, 2023. This Rights Plan includes enhanced shareholder protections, allowing shareholders to have a say on certain offers and potentially exempting some offers from the plan. It aims to prevent control or significant influence by an entity without fair compensation to all shareholders and encourages negotiation with the Board. The Rights Plan issues one right per share, exercisable if someone acquires 15%+ of shares without Board approval. It expires on December 19, 2024, and Meitar Law Offices and Wachtell, Lipton, Rosen & Katz are legal counsel to Stratasys.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:30 pm

CTAS

Over the past 20 years, Cintas (NASDAQ:CTAS) has produced an average annual return of 13.13%, outperforming the market by 5.63% on an annualized basis. A $100 investment in CTAS 20 years ago would be worth $1,174.97 today. Cintas currently has a market cap of $60.09 billion.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

PCAR

Over the past 5 years, PACCAR (NASDAQ:PCAR) has produced an average annual return of 20.81%, outperforming the market by 6.87% on an annualized basis. A $1000 investment in PCAR 5 years ago would be worth $2,708.22 today. PACCAR's market capitalization currently stands at $50.69 billion.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

CGC

CRBP

EAST

GENE

SMG

SOL

UGRO

On December 21, 2023, several marijuana stocks experienced significant price movements. Notable gainers included Blueberries Medical, iAnthus Capital Holdings, and Heritage Cannabis Holding, with increases of 15.05%, 14.44%, and 12.73% respectively. Emeren Group, Corbus Pharmaceuticals, and Scotts Miracle Gro also saw their shares rise. Conversely, MJ Holdings, Khiron Life Sciences, and Item 9 Labs were among the biggest losers, with MJ Holdings dropping 30.41%. Other notable declines were observed in Eastside Distilling, Genetic Technologies, Canopy Growth, and Cresco Labs.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

OPTT

PGNT

Paragon Technologies (PGNT) has issued a statement to Ocean Power Technologies (OPTT) shareholders, expressing concerns about OPTT's financial performance and stock price decline under the current Board and CEO. Paragon, owning 4.9% of OPTT, criticizes the Board for misleading optimism and poor capital management, suggesting OPT could be worth over $3 per share with better cost structure and focus on Marine Advanced Robotics. Paragon urges shareholders to vote for their Blue proxy card, proposing steps to improve OPTT's performance and threatening further action if the Board does not cooperate.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:26 pm

SQFT

Presidio Property Trust, Inc. (Presidio) has regained compliance with Nasdaq's minimum bid price requirement. The company's common stock maintained a closing bid price of $1.00 or more for 10 consecutive business days, satisfying Nasdaq Listing Rule 5550(a)(2). Nasdaq has confirmed that Presidio has met the requirement and considers the matter closed.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:25 pm

NKE

Nike reported Q2 sales of $13.39 billion, falling short of the expected $13.43 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:18 pm

NKE

Nike reported Q2 earnings of $1.03 per share, surpassing the consensus estimate of $0.85, representing a 21.18% year-over-year increase. Quarterly sales reached $13.39B, exceeding estimates of $12.43B and marking a 0.55% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:15 pm